Cardiovascular Systems

Cardiovascular Systems is a medical device company. CSI is focused on developing and commercializing minimally invasive treatment solutions for vascular disease. Our primary focus is helping physicians conquer even the most difficult disease states, including calcium, given the complications it presents for the millions who suffer from peripheral arterial disease (PAD) and coronary artery disease (CAD). CSI is committed to clinical rigor, constant innovation, and a defining drive to set the standard in safe, effective, economical medical devices that improve patient outcomes.

Company Growth (employees)
Type
Public
HQ
Saint Paul, US
Size (employees)
581 (est)
Cardiovascular Systems is headquartered in Saint Paul, US

Key People at Cardiovascular Systems

Scott R. Ward

Scott R. Ward

Chairman, President & CEO
Laurence L. Betterley

Laurence L. Betterley

CFO
Kevin J. Kenny

Kevin J. Kenny

Chief Operating Officer
James E. Flaherty

James E. Flaherty

CAO

Cardiovascular Systems Office Locations

Cardiovascular Systems has offices in Saint Paul, Rochester
Saint Paul, US
Saint Paul, US
Rochester, US

Cardiovascular Systems Metrics

Cardiovascular Systems Summary

Market capitalization

$870.5 m

Closing share price

$27
Cardiovascular Systems's current market capitalization is $870.5 m.

Cardiovascular Systems Financials

Cardiovascular Systems's revenue is $136.6 m in FY, 2014 which is a 24.7% decrease from the previous period.
FY, 2014FY, 2015FY, 2016

Revenue

$136.6 m$181.5 m$178.2 m

Revenue growth, %

32.9%(1.9%)

Gross profit

$105.6 m$142 m$142.8 m

Operating expense total

$139.1 m$174.7 m$198.8 m

EBIT

($33.5 m)($32.6 m)($56.1 m)

Net Income

($35.3 m)($32.8 m)($56 m)

Operating cash flow

$58.7 m($42.8 m)($23.2 m)

Cardiovascular Systems Market Value History

Cardiovascular Systems Company Life

You may also be interested in